• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Oracle to support Cancer Research U.K.’s development of targeted cancer therapies

Oracle to support Cancer Research U.K.’s development of targeted cancer therapies

July 17, 2012
CenterWatch Staff

To support its vision of beating cancer in the United Kingdom, Cancer Research U.K., , a not-for-profit cancer research organization, will work with Oracle Health Sciences Translational Research Center as the foundation for a new analytical environment to help the charity combine the genetic and clinical data from its Stratified Medicine Program.

Together with AstraZeneca, Pfizer and the U.K. government's Technology Strategy Board, Cancer Research U.K. is working to demonstrate a national service that will provide standardized, high-quality and cost-effective genetic testing of tumors linked to clinical data. This system has already tested 2,000 tumors from patients across 24 clinical sites and set up data capture covering diagnostics, genetics, treatment and outcomes.

Cancer Research U.K. will use Cohort Explorer, part of the Oracle Health Sciences Translational Research Center, to create a flexible, web-accessible analytical platform and interface that enables program affiliates to effectively and rapidly search and retrieve anonymized diagnostic, treatment and outcome data to accelerate research.

The platform will enable researchers and physicians to gain the insight needed to identify patient populations with similar characteristics and advance personalized cancer treatments.

The new analytical platform “is an exciting addition to the future of our Stratified Medicine Program and its goal of combining genetic testing of tumors with clinical data capture to determine more effective treatment,” said Monica Jones, enterprise architect and informatics lead of Cancer Research U.K.’s Stratified Medicine Program.

“Organizations committed to advancing medical science require powerful analytical solutions to reveal insight that was previously locked away at the molecular level,” said Neil de Crescenzo, senior vice president and general manager of Oracle Health Sciences.

Cancer Research U.K. is a leading cancer charity dedicated to saving lives through research. Its groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives, and is funded entirely by the public. It supports the research of more than 4,000 scientists, doctors and nurses.

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing